EA202192716A1 - Состав вагинальных таблеток - Google Patents

Состав вагинальных таблеток

Info

Publication number
EA202192716A1
EA202192716A1 EA202192716A EA202192716A EA202192716A1 EA 202192716 A1 EA202192716 A1 EA 202192716A1 EA 202192716 A EA202192716 A EA 202192716A EA 202192716 A EA202192716 A EA 202192716A EA 202192716 A1 EA202192716 A1 EA 202192716A1
Authority
EA
Eurasian Patent Office
Prior art keywords
composition
vaginal tablets
vaginal
tablets
lactone
Prior art date
Application number
EA202192716A
Other languages
English (en)
Inventor
Ульф Эллервик
Софи Маннер
Олов Стернер
Хелена Стревенс
Нильс-Олоф ЛИНДБЕРГ
Аннетт Сафхольм
Original Assignee
Гедеа Байотек Аб
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Гедеа Байотек Аб filed Critical Гедеа Байотек Аб
Publication of EA202192716A1 publication Critical patent/EA202192716A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina

Abstract

Изобретение относится к фармацевтической композиции, содержащей глюконо--лактон, которая является подходящей для применения при лечении вагинальных микробных инфекций.
EA202192716A 2019-04-05 2020-04-03 Состав вагинальных таблеток EA202192716A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP19167495 2019-04-05
PCT/EP2020/059582 WO2020201515A1 (en) 2019-04-05 2020-04-03 Vaginal tablet formulation

Publications (1)

Publication Number Publication Date
EA202192716A1 true EA202192716A1 (ru) 2022-01-17

Family

ID=66101895

Family Applications (1)

Application Number Title Priority Date Filing Date
EA202192716A EA202192716A1 (ru) 2019-04-05 2020-04-03 Состав вагинальных таблеток

Country Status (24)

Country Link
US (1) US20220193031A1 (ru)
EP (1) EP3976000B1 (ru)
JP (1) JP2022537478A (ru)
KR (1) KR20210148195A (ru)
CN (1) CN113660928B (ru)
AR (1) AR118580A1 (ru)
AU (1) AU2020252268A1 (ru)
BR (1) BR112021019999A2 (ru)
CA (1) CA3134086A1 (ru)
CL (1) CL2021002430A1 (ru)
CO (1) CO2021014253A2 (ru)
EA (1) EA202192716A1 (ru)
ES (1) ES2961736T3 (ru)
HU (1) HUE062772T2 (ru)
IL (1) IL286942A (ru)
MA (1) MA56011A (ru)
MX (1) MX2021012146A (ru)
PE (1) PE20220381A1 (ru)
PL (1) PL3976000T3 (ru)
SG (1) SG11202110236QA (ru)
TW (1) TW202103693A (ru)
UA (1) UA127823C2 (ru)
WO (1) WO2020201515A1 (ru)
ZA (1) ZA202106877B (ru)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69802260T2 (de) * 1998-04-30 2002-07-04 Vesely Renata Maria Cavaliere Pharmazeutische Zusammensetzungen enthaltend Lactobacillus brevis und Lactobacillus salivarius zur Behandlung von Vaginainfektionen
US6287599B1 (en) * 2000-12-20 2001-09-11 Shire Laboratories, Inc. Sustained release pharmaceutical dosage forms with minimized pH dependent dissolution profiles
US20030017207A1 (en) * 2001-05-01 2003-01-23 Lin Shun Y. Compositions and methods for treating vulvovaginitis and vaginosis
ITBO20110461A1 (it) * 2011-07-29 2013-01-30 Alfa Wassermann Spa Composizioni farmaceutiche comprendenti rifaximina, processi per la loro preparazione e loro uso nel trattamento di infezioni vaginali.
PL3439633T3 (pl) * 2016-04-06 2022-01-10 Gedea Biotech Ab Glukono-delta-lakton w leczeniu zakażeń grzybiczych pochwy
UA126590C2 (uk) 2017-10-06 2022-11-02 Гедеа Біотеч Аб Похідні глюконової кислоти для застосування в лікуванні та/або попередженні інфекцій, спричинених мікроорганізмами

Also Published As

Publication number Publication date
KR20210148195A (ko) 2021-12-07
UA127823C2 (uk) 2024-01-10
MA56011A (fr) 2022-04-06
BR112021019999A2 (pt) 2021-12-07
EP3976000C0 (en) 2023-08-02
TW202103693A (zh) 2021-02-01
EP3976000B1 (en) 2023-08-02
CL2021002430A1 (es) 2022-07-01
CN113660928A (zh) 2021-11-16
CO2021014253A2 (es) 2021-11-19
CA3134086A1 (en) 2020-10-08
CN113660928B (zh) 2024-04-05
SG11202110236QA (en) 2021-10-28
AR118580A1 (es) 2021-10-20
WO2020201515A1 (en) 2020-10-08
ZA202106877B (en) 2023-03-29
PE20220381A1 (es) 2022-03-18
HUE062772T2 (hu) 2023-12-28
MX2021012146A (es) 2021-12-10
AU2020252268A1 (en) 2021-10-21
IL286942A (en) 2021-12-01
EP3976000A1 (en) 2022-04-06
US20220193031A1 (en) 2022-06-23
JP2022537478A (ja) 2022-08-26
PL3976000T3 (pl) 2023-12-04
ES2961736T3 (es) 2024-03-13

Similar Documents

Publication Publication Date Title
MY196909A (en) Boronic acid derivatives and therapeutic uses thereof
CL2016000106A1 (es) Sulfonamidas como moduladores de canales de sodio.
EA201990043A1 (ru) Антибактериальные соединения
NZ733174A (en) Quinazoline derivatives used to treat hiv
UA116648C2 (uk) Фумарати як проліки та їх застосування при лікуванні різних захворювань
EA201691988A1 (ru) Производные бороновой кислоты и их терапевтическое применение
GEP20227406B (en) Chromane monobactam compounds for the treatment of bacterial infections
EA201690687A1 (ru) Ингибиторы репликации вируса иммунодефицита
EA201591406A1 (ru) C-19 модифицированные тритерпеноиды с ингибиторной активностью созревания вич
EA201591541A1 (ru) Ингибиторы бета-секретазы 1 (bace 1)
BR112016016853A2 (pt) Compostos contendo nitrogênio, seu uso e seu processo de preparação, composição farmacêutica e seu uso
EA202090014A1 (ru) Гетероароматические соединения в качестве ингибиторов ванина
EA202091118A1 (ru) Антибактериальные соединения
CR20210507A (es) Composición farmacéutica acuosa de anticuerpo anti-il17a y su uso
CL2017002229A1 (es) Inhibidores de bace1.
PH12019502332A1 (en) Treatment of a bacterial vaginal infection
EA201500737A1 (ru) Пиразолилкарбоксамиды ii в качестве ингибиторов crac каналов
EA201500736A1 (ru) Пиразолилкарбоксамиды i в качестве ингибиторов crac каналов
BR112016029619A2 (pt) novas fluoroquinolonas e sesu usos no tratamento de infecções bacterianas
EA202091169A1 (ru) Применяемые в качестве ингибиторов iap миметики smac и их применение
BR112019017314A2 (pt) composições farmacêuticas para terapia de combinação
EA202192716A1 (ru) Состав вагинальных таблеток
PH12016502480A1 (en) Compounds, pharmaceutical composition and their use in treating neurodegenerative diseases
EA201270547A1 (ru) Фармацевтическая композиция
MX360040B (es) Nuevo agente antibacteriano derivado de florfenicol unido a sulfoximina y el uso del mismo en el tratamiento de infecciones bacterianas en ganado vacuno.